Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction
about
Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction
description
clinical trial
@en
klinisch onderzoek
@nl
name
Bortezomib, Paclitaxel, and Ca ...... s or Gastroesophageal Junction
@en
type
label
Bortezomib, Paclitaxel, and Ca ...... s or Gastroesophageal Junction
@en
prefLabel
Bortezomib, Paclitaxel, and Ca ...... s or Gastroesophageal Junction
@en
P4844
P1476
A Phase II Trial of PS-341 in ...... l Junction, and Gastric Cardia
@en
P3098
NCT00107341
P580
2005-08-01T00:00:00Z
P582
2007-02-01T00:00:00Z